ASX/CUV (ASX/CUV)

Australian Securities Exchange: ASX/CUV · AUD

A$7.33

+0.15 (+2.1%)· Recorded snapshot

Market cap	369.6M
Revenue (ttm)	94M
Net income (ttm)	33.9M
EPS (ttm)	A$0.67
Shares out	50.4M
P/E (trailing)	11.0x
P/E (forward)	10.8x
Dividend	A$0.05 (0.68%)
Volume	140,870
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 94M
Net income (ttm): 33.9M
EPS (ttm): A$0.67
P/E (trailing): 11.0x
P/E (forward): 10.8x
Market cap: 369.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E10.8

P25 n/aP50 n/aP75 n/a

Trailing P/E11

P25 n/aP50 n/aP75 n/a

ROE13.2

P25 n/aP50 n/aP75 n/a

ROIC126.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All ASX/CUV indicators

Market & fundamental data

Available fields

260

Groups with data

Currency

AUD

Showing 260 of 260 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-08-27
Employees	16
Enterprise value	AUD 119.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1999
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000CUV3
Last earnings date	2026-08-27
Last refreshed	2026-10-29
Last stock split date	2010-11-12
Last stock split type	Reverse
Market cap	AUD 369.6M
Price	AUD 7.33
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/CUV
Website	https://www.clinuvel.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	10.97x
Average P/E ratio (10Y)	48.07x
Average P/E ratio (3Y)	18.72x
Average P/E ratio (5Y)	29.23x
Earnings yield	9.11%
EV/Earnings	3.52x
EV/EBIT	2.95x
EV/EBITDA	2.88x
EV/FCF	3.39x
EV/Sales	1.27x
FCF / EV yield	29.54%
FCF yield	9.55%
Forward P/E	10.8x
Graham number	9.01842
Graham upside	23.03%
Industry forward P/E	28.88x
Lynch fair value	AUD 4.36
Lynch upside	-40.55%
P/(FCF - SBC) ratio	11.21x
P/(OCF - SBC) ratio	10.69x
P/B ratio	1.35x
P/E ratio	10.97x
P/FCF ratio	10.47x
P/OCF ratio	10.01x
P/S ratio	3.93x
Price / tangible book value	1.36x
Price/EBITDA ratio	8.99x
Sector forward P/E	34.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	43.11%
EBITDA margin	43.72%
Effective tax rate	28.84%
FCF margin	37.55%
Gross margin	83.18%
Operating margin	43.11%
Pretax margin	50.69%
Profit margin	36.07%
Profit per employee	AUD 2.1M
Profitable quarters	21
Profitable years	10
Revenue per employee	AUD 5.9M
ROA	8.94%
ROA (5Y)	13.48%
ROCE	14.69%
ROE	13.21%
ROE (5Y)	17.72%
ROIC	126.71%
SBC / revenue	2.49%
Tax / revenue	14.62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-6.96%
EPS growth (Q)	5.35%
EPS growth (QoQ)	123.49%
EPS growth 3Y	4.17%
EPS growth 5Y	6.66%
EPS growth quarters	1
EPS growth years	0
FCF growth	-13.46%
FCF growth (Q)	-17.22%
FCF growth (QoQ)	85.31%
FCF growth 3Y	-0.54%
FCF growth 5Y	13.91%
Gross profit growth	-2.49%
Gross profit growth (Q)	-3.72%
Gross profit growth 3Y	3.37%
Gross profit growth 5Y	12.12%
Net income growth	-6.24%
Net income growth (Q)	6.23%
Net income growth (QoQ)	124.79%
Net income growth 3Y	3.48%
Net income growth 5Y	6.52%
Net income growth quarters	1
Net income growth years	0
OCF growth	-10.19%
OCF growth (Q)	-12.73%
OCF growth (QoQ)	94.69%
OCF growth 3Y	-0%
OCF growth 5Y	13.89%
Operating income growth	-1.79%
Operating income growth (Q)	8.08%
Operating income growth 3Y	-2.79%
Operating income growth 5Y	7.25%
Revenue growth	-1.05%
Revenue growth (Q)	-3.84%
Revenue growth (QoQ)	54.6%
Revenue growth 10Y	30%
Revenue growth 3Y	6.28%
Revenue growth 5Y	14.24%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -1.6M
Depreciation and amortization	AUD 576,594
EBIT	AUD 40.5M
EBITDA	AUD 41.1M
EPS	AUD 0.67
FCF per share	AUD 0.70
Financing cash flow	AUD -2.8M
Free cash flow	AUD 35.3M
Free cash flow minus SBC	AUD 33M
Gross profit	AUD 78.2M
Income taxes	AUD 13.7M
Investing cash flow	AUD -39.1M
Net borrowing	AUD -238,643
Net cash flow	AUD -6.6M
Net income	AUD 33.9M
Operating cash flow minus SBC	AUD 34.6M
Operating income	AUD 40.5M
Revenue	AUD 94M
Stock-based compensation	AUD 2.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	17.18
Book value per share	AUD 5.41
Debt / EBITDA	0.05
Debt / equity	0.01
Debt / FCF	0.05
Long-term assets	AUD 10.5M
Long-term liabilities	AUD 3M
Net cash (debt)	AUD 250.1M
Net cash / market cap	67.67%
Net cash growth	11.87%
Net debt / EBITDA	-6.08
Net debt / equity	-0.92
Net debt / FCF	-7.08
Piotroski F-Score	5
Property, plant and equipment	AUD 9.2M
Shareholders' equity	AUD 272.9M
Tangible book value	AUD 272.7M
Tangible book value per share	AUD 5.41
Total assets	AUD 295.1M
Total cash	AUD 252.1M
Total debt	AUD 1.9M
Total liabilities	AUD 22.2M
WACC	7.4%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.33
Current assets	AUD 284.6M
Current liabilities	AUD 19.2M
Current ratio	14.81
Inventory turnover	2.01
Net working capital	AUD 13.7M
Quick ratio	14.34
Working capital	AUD 265.4M
Working capital turnover	0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.73%
Dividend growth	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	14.87%
Dividend growth years	0
Dividend payment date	2026-09-18
Dividend payment years	9
Dividend payout frequency	Annual
Dividend per share	AUD 0.05
Dividend yield	0.68%
Ex-dividend date	2026-09-03
FCF payout ratio	7.14%
Last dividend	AUD 0.05
Payout ratio	7.39%
Shareholder yield	-0.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-20.24%
10Y return CAGR	-2.01%
10Y total return	-18.4%
150-day SMA	AUD 9.08
15Y price change	372.9%
15Y return CAGR	11.08%
15Y total return	383.83%
1D price change	2.09%
1M price change	-10.28%
1M total return	-10.28%
1W price change	3.68%
1W total return	3.68%
1Y price change	-35.19%
1Y return CAGR	-34.82%
1Y total return	-34.8%
20-day SMA	AUD 7.60
200-day SMA	AUD 9.50
20Y price change	78.78%
20Y return CAGR	3.07%
20Y total return	82.91%
3M price change	-25.28%
3M total return	-24.83%
3Y price change	-52.12%
3Y return CAGR	-21.4%
3Y total return	-51.44%
50-day SMA	AUD 8.18
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 13.48
52-week high date	2026-01-12
52-week low	AUD 6.62
52-week low date	2026-10-20
5Y price change	-80.99%
5Y return CAGR	-27.98%
5Y total return	-80.62%
6M price change	-19.72%
6M total return	-19.23%
All-time high	AUD 45.88
All-time high date	2019-10-09
All-time low	AUD 0.45
All-time low date	2001-09-25
Average true range (ATR)	AUD 0.33
Average volume	159.2K
Beta (1Y)	0.07
Beta (2Y)	0.6
Beta (5Y)	0.58
Change from 52-week high	-45.62%
Change from 52-week low	10.73%
Change from all-time high	-84.02%
Change from all-time low	1,528.89%
Change from open	1.81%
Day's gap	0.28%
Dollar volume	AUD 1M
High price	AUD 7.40
Low price	AUD 7.13
Monthly RSI	34.15
Open price	AUD 7.20
Position in 52-week range	74.07%
Previous close	AUD 7.18
Price vs 150-day SMA	-19.25%
Price vs 20-day SMA	-3.58%
Price vs 200-day SMA	-22.87%
Price vs 50-day SMA	-10.35%
Relative volume	0.89
RSI	40.2
Sharpe ratio	-0.95
Sharpe ratio (3Y)	-0.45
Sharpe ratio (5Y)	-0.59
Sortino ratio	-1.14
Sortino ratio (3Y)	-0.5
Sortino ratio (5Y)	-0.69
Volume	140.9K
Weekly RSI	35.15
YTD price change	-41.17%
YTD total return	-40.82%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42.1M
Shares change (QoQ)	0.51%
Shares change (YoY)	0.73%
Shares held by insiders	10%
Shares held by institutions	23.21%
Shares outstanding	50.4M

Deeper analysis on ASX/CUV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this ASX/CUV report

Is a complete ASX/CUV research report available?

No complete published report is available for asx/CUV (ASX/CUV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

369.6M

Revenue (ttm)

94M

Net income (ttm)

33.9M

EPS (ttm)

A$0.67

Shares out

50.4M

P/E (trailing)

11.0x

P/E (forward)

10.8x

Dividend

A$0.05 (0.68%)

Volume

140,870

Beta

0.58

Metric

Value

Amount currency

AUD

Country

Australia

Country code

Earnings date

2026-08-27

Employees

Enterprise value

AUD 119.5M

Exchange

Australian Securities Exchange

Financial currency

AUD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

June

Founded

1999

Industry

Biotechnology

Is primary listing

Yes

ISIN number

AU000000CUV3

Last earnings date

2026-08-27

Last refreshed

2026-10-29

Last stock split date

2010-11-12

Last stock split type

Reverse

Market cap

AUD 369.6M

Price

AUD 7.33

Price currency

AUD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-29

Symbol

asx/CUV

Website

https://www.clinuvel.com

Metric

Value

Adjusted P/E ratio

10.97x

Average P/E ratio (10Y)

48.07x

Average P/E ratio (3Y)

18.72x

Average P/E ratio (5Y)

29.23x

Earnings yield

9.11%

EV/Earnings

3.52x

EV/EBIT

2.95x

EV/EBITDA

2.88x

EV/FCF

3.39x

EV/Sales

1.27x

FCF / EV yield

29.54%

FCF yield

9.55%

Forward P/E

10.8x

Graham number

9.01842

Graham upside

23.03%

Industry forward P/E

28.88x

Lynch fair value

AUD 4.36

Lynch upside

-40.55%

P/(FCF - SBC) ratio

11.21x

P/(OCF - SBC) ratio

10.69x

P/B ratio

1.35x

P/E ratio

10.97x

P/FCF ratio

10.47x

P/OCF ratio

10.01x

P/S ratio

3.93x

Price / tangible book value

1.36x

Price/EBITDA ratio

8.99x

Sector forward P/E

34.2x

Metric

Value

EBIT margin

43.11%

EBITDA margin

43.72%

Effective tax rate

28.84%

FCF margin

37.55%

Gross margin

83.18%

Operating margin

43.11%

Pretax margin

50.69%

Profit margin

36.07%

Profit per employee

AUD 2.1M

Profitable quarters

Profitable years

Revenue per employee

AUD 5.9M

ROA

8.94%

ROA (5Y)

13.48%

ROCE

14.69%

ROE

13.21%

ROE (5Y)

17.72%

ROIC

126.71%

SBC / revenue

2.49%

Tax / revenue

14.62%

Metric

Value

EPS growth

-6.96%

EPS growth (Q)

5.35%

EPS growth (QoQ)

123.49%

EPS growth 3Y

4.17%

EPS growth 5Y

6.66%

EPS growth quarters

EPS growth years

FCF growth

-13.46%

FCF growth (Q)

-17.22%

FCF growth (QoQ)

85.31%

FCF growth 3Y

-0.54%

FCF growth 5Y

13.91%

Gross profit growth

-2.49%

Gross profit growth (Q)

-3.72%

Gross profit growth 3Y

3.37%

Gross profit growth 5Y

12.12%

Net income growth

-6.24%

Net income growth (Q)

6.23%

Net income growth (QoQ)

124.79%

Net income growth 3Y

3.48%

Net income growth 5Y

6.52%

Net income growth quarters

Net income growth years

OCF growth

-10.19%

OCF growth (Q)

-12.73%

OCF growth (QoQ)

94.69%

OCF growth 3Y

-0%

OCF growth 5Y

13.89%

Operating income growth

-1.79%

Operating income growth (Q)

8.08%

Operating income growth 3Y

-2.79%

Operating income growth 5Y

7.25%

Revenue growth

-1.05%

Revenue growth (Q)

-3.84%

Revenue growth (QoQ)

54.6%

Revenue growth 10Y

30%

Revenue growth 3Y

6.28%

Revenue growth 5Y

14.24%

Revenue growth years

Metric

Value

Capital expenditures

AUD -1.6M

Depreciation and amortization

AUD 576,594

EBIT

AUD 40.5M

EBITDA

AUD 41.1M

EPS

AUD 0.67

FCF per share

AUD 0.70

Financing cash flow

AUD -2.8M

Free cash flow

AUD 35.3M

Free cash flow minus SBC

AUD 33M

Gross profit

AUD 78.2M

Income taxes

AUD 13.7M

Investing cash flow

AUD -39.1M

Net borrowing

AUD -238,643

Net cash flow

AUD -6.6M

Net income

AUD 33.9M

Operating cash flow minus SBC

AUD 34.6M

Operating income

AUD 40.5M

Revenue

AUD 94M

Stock-based compensation

AUD 2.3M

Metric

Value

Altman Z-Score

17.18

Book value per share

AUD 5.41

Debt / EBITDA

0.05

Debt / equity

0.01

Debt / FCF

0.05

Long-term assets

AUD 10.5M

Long-term liabilities

AUD 3M

Net cash (debt)

AUD 250.1M

Net cash / market cap

67.67%

Net cash growth

11.87%

Net debt / EBITDA

-6.08

Net debt / equity

-0.92

Net debt / FCF

-7.08

Piotroski F-Score

Property, plant and equipment

AUD 9.2M

Shareholders' equity

AUD 272.9M

Tangible book value

AUD 272.7M

Tangible book value per share

AUD 5.41

Total assets

AUD 295.1M

Total cash

AUD 252.1M

Total debt

AUD 1.9M

Total liabilities

AUD 22.2M

WACC

7.4%

Metric

Value

Asset turnover

0.33

Current assets

AUD 284.6M

Current liabilities

AUD 19.2M

Current ratio

14.81

Inventory turnover

2.01

Net working capital

AUD 13.7M

Quick ratio

14.34

Working capital

AUD 265.4M

Working capital turnover

0.38

Metric

Value

Buyback yield / dilution

-0.73%

Dividend growth

Dividend growth (3Y)

Dividend growth (5Y)

14.87%

Dividend growth years

Dividend payment date

2026-09-18

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

AUD 0.05

Dividend yield

0.68%

Ex-dividend date

2026-09-03

FCF payout ratio

7.14%

Last dividend

AUD 0.05

Payout ratio

7.39%

Shareholder yield

-0.05%

Metric

Value

10Y price change

-20.24%

10Y return CAGR

-2.01%

10Y total return

-18.4%

150-day SMA

AUD 9.08

15Y price change

372.9%

15Y return CAGR

11.08%

15Y total return

383.83%

1D price change

2.09%

1M price change

-10.28%

1M total return

-10.28%

1W price change

3.68%

1W total return

3.68%

1Y price change

-35.19%

1Y return CAGR

-34.82%

1Y total return

-34.8%

20-day SMA

AUD 7.60

200-day SMA

AUD 9.50

20Y price change

78.78%

20Y return CAGR

3.07%

20Y total return

82.91%

3M price change

-25.28%

3M total return

-24.83%

3Y price change

-52.12%

3Y return CAGR

-21.4%

3Y total return

-51.44%

50-day SMA

AUD 8.18

50-day SMA vs 200-day SMA

50under200

52-week high

AUD 13.48

52-week high date

2026-01-12

52-week low

AUD 6.62

52-week low date

2026-10-20

5Y price change

-80.99%

5Y return CAGR

-27.98%

5Y total return

-80.62%

6M price change

-19.72%

6M total return

-19.23%

All-time high

AUD 45.88

All-time high date

2019-10-09

All-time low

AUD 0.45

All-time low date

2001-09-25

Average true range (ATR)

AUD 0.33

Average volume

159.2K

Beta (1Y)

0.07

Beta (2Y)

0.6

Beta (5Y)

0.58

Change from 52-week high

-45.62%

Change from 52-week low

10.73%

Change from all-time high

-84.02%

Change from all-time low

1,528.89%

Change from open

1.81%

Day's gap

0.28%

Dollar volume

AUD 1M

High price

AUD 7.40

Low price

AUD 7.13

Monthly RSI

34.15

Open price

AUD 7.20

Position in 52-week range

74.07%

Previous close

AUD 7.18

Price vs 150-day SMA

-19.25%

Price vs 20-day SMA

-3.58%

Price vs 200-day SMA

-22.87%

Price vs 50-day SMA

-10.35%

Relative volume

0.89

RSI

40.2

Sharpe ratio

-0.95

Sharpe ratio (3Y)

-0.45

Sharpe ratio (5Y)

-0.59

Sortino ratio

-1.14

Sortino ratio (3Y)

-0.5

Sortino ratio (5Y)

-0.69

Volume

140.9K

Weekly RSI

35.15

YTD price change

-41.17%

YTD total return

-40.82%

Metric

Value

Float

42.1M

Shares change (QoQ)

0.51%

Shares change (YoY)

0.73%

Shares held by insiders

10%

Shares held by institutions

23.21%

Shares outstanding

50.4M

ASX/CUV (ASX/CUV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CUV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CUV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CUV

Frequently asked questions

ASX/CUV (ASX/CUV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CUV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CUV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CUV

Frequently asked questions